BioWorld

Jan. 17, 2006

View Archived Issues

Genelabs' Prestara Headed For New Phase III Lupus Trial

Forging ahead with its lupus drug, Prestara, Genelabs Technologies Inc. has decided to conduct another Phase III trial, and likely will look for a development partner to help offset costs. (BioWorld Today) Read More

Biotech's Redemption Chance: Make Drugs, Foster Community

Read More

Human Bird Flu Data: Less Severe, But More Prevalent

Read More

FDA Unveils Guidance To Ease Early Stage Clinical Evaluations

Read More

Other News To Note

Read More